Navigation Links
Martek Biosciences Inducted into Small Business Innovation Research (SBIR) Hall of Fame
Date:2/17/2011

COLUMBIA, Md., Feb. 17, 2011 /PRNewswire/ -- Martek Biosciences Corporation (Nasdaq: MATK), a leader in the innovation, development, production and sales of high-value products from microbial sources that promote health and wellness through nutrition, announced today that it has been inducted into the inaugural Small Business Innovation Research (SBIR) Hall of Fame, a program under the U.S. Small Business Administration. Martek Biosciences was recognized for its success in research, innovation and commercialization within the SBIR program. Martek was honored at the national inductee ceremony held on February 15, 2011 in Washington, DC, followed by a White House reception.  

"We are honored to be one of only eight companies inducted into the first-ever SBIR Hall of Fame," said Steve Dubin, CEO of Martek Biosciences. "Our success over the past 26 years has been realized in part from the funding and support we received through the SBIR program during our early start-up stage. What started with a few visionary and passionate scientists is now a company with more than 600 employees, revenues of more than $450 million and a thriving and robust technology pipeline."

SBIR is a highly-competitive program that encourages small businesses to explore their technological potential and provides the incentive to profit from its commercialization. By including qualified small businesses in the nation's R&D arena, high-tech innovation is stimulated and the United States gains entrepreneurial spirit and grows jobs as it meets its specific research and development needs.

All SBIR Hall of Fame award winners were selected by the SBA based on the recommendations of a panel of judges. Inductees were evaluated based on a company's technical innovation, business impact, broader social and economic benefit, degree of impact and longevity.

About MartekMartek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation, development, production and sales of high-value products from microbial sources that promote health and wellness through nutrition.  The company is the world's leading provider of algal DHA omega-3 with its flagship product, life'sDHA™, a sustainable and vegetarian source of algal DHA omega-3 important for brain, heart and eye health throughout life, for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA™ (arachidonic acid), an omega-6 fatty acid, for use in infant formula and growing up milks. Additionally, Martek's subsidiary, Amerifit Brands, develops, markets and distributes branded consumer health and wellness products in major mass, club, drug, grocery and specialty stores and holds leading brand positions in all of its key product categories. For more information on Martek Biosciences, visit http://www.martek.com/. For information about life'sDHA or life'sARA products, visit www.lifesdha.com/ or www.algaldha.com. For more information about Amerifit Brands, visit www.amerifit.com.

Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company's filings with the Securities and Exchange Commission, including, but not limited to, the company's Form 10-K for the fiscal year ended October 31, 2010 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.Contact:Cassie France-KellyPublic Relations (443) 542-2116media@martek.comKyle StultsInvestor Relations(410) 740-0081investors@martek.com
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years
2. Martek Announces Fourth Quarter and FY 2010 Financial Results
3. Martek to Present at Upcoming Citi Small / Mid Cap Conference
4. Martek to Present at Upcoming UBS Conference
5. Martek Announces Third Quarter FY 2010 Financial Results
6. Martek Announces Fourth Quarter and FY 2009 Financial Results
7. Martek Signs Sole-Source Supply Agreement with Fonterra
8. Martek to Announce Fourth Quarter and Fiscal Year 2009 Results
9. Martek Announces Addition to Its Board of Directors
10. Martek to Present at Two Upcoming Investor Conferences
11. Martek Announces Settlement of Patent Dispute with Capsugel France
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... ... 13 prestigious awards honoring scientists who have made outstanding contributions ... scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for laboratory ...
(Date:10/9/2017)... (PRWEB) , ... October 09, 2017 , ... At its ... Dr. Christopher Stubbs, a professor in Harvard University’s Departments of Physics and Astronomy, has ... was a member of the winning team for the 2015 Breakthrough Prize in Fundamental ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... instruments and applications consulting for microscopy and surface analysis, Nanoscience Instruments is ... Nanoscience Analytical offers a broad range of contract analysis services for advanced ...
(Date:10/6/2017)... ... October 06, 2017 , ... The HealthTech Venture ... sector at their fourth annual Conference where founders, investors, innovative practitioners and collaborators ... ELEVATE pitch competition showcasing early stage digital health and med tech companies. , ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):